Chemie raises full-year sales guidance on strong new business

By Reuters News

Oct 22 (Reuters) - Swiss chemicals maker EMS-Chemie EMSN.S lifted its full-year sales forecast on Thursday, citing strong new business despite weak consumer sentiment and a struggling global automotive industry.

The group's earnings provide an early read-through for larger European chemical groups reporting later this month. The sector continues to grapple with weak demand, global overcapacity and high energy costs, although business sentiment has improved and supply disruptions linked to the Middle East war have provided some support.


  • The company now expects full-year sales to be in line with last year's level, up from its previous forecast for a slight decline.

  • EMS said it is developing new business in growth areas including electric vehicles, robotics and data centres.

  • It reported nine-month sales of 1.51 billion Swiss francs ($1.82 billion), up marginally from 1.49 billion francs a year earlier.

  • EMS said the stronger Swiss franc weighed on sales in reported terms, while sales rose 4.2% in local currencies.

  • The group continues to expect EBIT in 2026 slightly above previous year.





($1 = 0.8226 Swiss francs)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.